Healthcare

Final FLAURA2 Results Confirm Survival Advantage of Tagrisso Plus Chemotherapy in Advanced EGFRm Lung Cancer

(IN BRIEF) Final overall survival results from AstraZeneca’s FLAURA2 Phase III trial confirm that combining Tagrisso with chemotherapy significantly improves…

4 months ago

Sanofi Finalizes Blueprint Medicines Deal Adding Ayvakit and Robust SM Pipeline

(IN BRIEF) Sanofi has completed its purchase of Blueprint Medicines, acquiring the approved systemic mastocytosis therapy Ayvakit/Ayvakyt (avapritinib), along with…

4 months ago

Trained Dogs Achieve Up to 98% Accuracy in Detecting Parkinson’s Disease from Skin Swabs

(IN BRIEF) A collaborative study by the University of Bristol, Medical Detection Dogs, and the University of Manchester found that…

4 months ago